Source disclosure: February 19, 2026
TRANSGENIC GROUP INC. [2342.T]
TOKYO, Feb 19 (Pulse News Wire) – Transgenic Group Inc. (2342.T) announced today that its shares have been transferred from the Tokyo Stock Exchange Growth Market to the Standard Market.
"We extend our heartfelt gratitude to our shareholders and all stakeholders who have supported us," said President Kengo Fukunaga. "This move reflects our commitment to sustainable growth and enhancing long-term corporate value." The company has expanded its drug development support services through mergers and acquisitions, covering stages from early drug discovery to non-clinical and clinical trials.
It plans to continue advancing its initiatives aimed at contributing to global health and prosperity. Transgenic Group remains dedicated to its mission and looks forward to continued support from its stakeholders.
AI-translated content. 🟢 Confidence: High See terms • Original filing